Struggling Perrigo OKs pharma split by Carly Helfand Thursday, August 9, 2018 It was nearly two years ago that activist investors began urging Perrigo to hive off its specialty pharma unit. Now, it’s finally happening.
Activist pressure spurs CEO switch at troubled Depomed by Carly Helfand Wednesday, March 29, 2017 Last October, Depomed switched up its board to appease activist Starboard Value. But Starboard didn’t stop there, and now Depmed has a new CEO.
Embattled Perrigo slashes 750 jobs, loses CFO by Carly Helfand Tuesday, February 28, 2017 Floundering Perrigo’s CFO is hitting the road—along with hundreds of other employees, who didn’t have quite as much say in the matter.
Perrigo hands activist Starboard 5 boardroom seats by Carly Helfand Tuesday, February 7, 2017 Perrigo and its activist investor have come to an agreement, and it’s one that’ll overhaul the company’s board.
Depomed strikes deal with Starboard to end proxy fight by Carly Helfand Tuesday, October 18, 2016 Depomed and activist investor Starboard Value have reached a settlement, putting an end to a months-long proxy fight. But what's next for the California drugmaker?
